Bottom line
What is PTSRX's expense ratio?
PTSRX's expense ratio is 1.03%, or about $103 a year on every $10,000 invested. That is more expensive than 90% of short-term bond funds we track (median 0.47%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Jul 28, 2026
PTSRX fee table
| Net expense ratio | 1.03% |
|---|---|
| Gross expense ratio | 1.03% |
| Management fee | 0.45% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.08% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jul 28, 2026
What PTSRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PTSRX | $105 | $328 | $569 | $1,259 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.03% expense ratio costs roughly $56,900 in lost growth, versus about $27,300 for the median short-term bond fund (0.47%).